Mantle Cell Lymphoma: Drug Combo Improves PFS Mantle Cell Lymphoma: Drug Combo Improves PFS

' In the countries where ibrutinib is indicated, this combination should be a new standard therapy for relapsed/refractory mantle cell lymphoma. 'MDedge News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news